Ephrin-B2 controls PDGFRβ internalization and signaling

Genes and Development

Volumn 27, Issue 23, 2013, Pages 2576-2589

  Nakayama, Akiko ^a,b   Nakayama, Masanori ^a,b   Turner, Christopher J ^c   Höing, Susanne ^a   Lepore, John J ^d   Adams, Ralf H ^a,b,c  

^a MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d GLAXOSMITHKLINE   (United States)

Author keywords

PDGF; Receptor; Signaling; Tyrosine kinase

Indexed keywords

CAVEOLIN; CLATHRIN; EPHRIN B2; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RAC1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL FRACTIONATION; CELL MEMBRANE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

PDGF; RECEPTOR; SIGNALING; TYROSINE KINASE;

ANIMALS; CELL MEMBRANE; CELLS, CULTURED; EPHRIN-B2; FEMALE; MALE; MICE; MUTATION; MYOCYTES, SMOOTH MUSCLE; PROTEIN TRANSPORT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION;

EID: 84889063291     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.224089.113     Document Type: Article

References (47)

1. Abella JV, Park M. 2009. Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases. Am J Physiol Endocrinol Metab 296: E973-E984.
2. Andrae J, Gallini R, Betsholtz C. 2008. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22: 1276-1312.
3. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, et al. 2002. β-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111: 251-263.
4. Bethani I, Skanland SS, Dikic I, Acker-Palmer A. 2010. Spatial organization of transmembrane receptor signalling. EMBO J 29: 2677-2688.
5. Bond M, Wu YJ, Sala-Newby GB, Newby AC. 2008. Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo. Cardiovasc Res 80: 290-298.
6. Boucher P, Gotthardt M, Li WP, Anderson RG, Herz J. 2003. LRP: Role in vascular wall integrity and protection from atherosclerosis. Science 300: 329-332.
7. Chow JC, Condorelli G, Smith RJ. 1998. Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway. J Biol Chem 273: 4672-4680.
8. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. 2003. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nat Cell Biol 5: 410-421.
9. Finger EC, Lee NY, You HJ, Blobe GC. 2008. Endocytosis of the type III transforming growth factor-β (TGF-β) receptor through the clathrin-independent/lipid raft pathway regulates TGF-β signaling and receptor down-regulation. J Biol Chem 283: 34808-34818.
10. Foo SS, Turner CJ, Adams S, Compagni A, Aubyn D, Kogata N, Lindblom P, Shani M, Zicha D, Adams RH. 2006. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124: 161-173.
11. Forsberg K, Valyi-Nagy I, Heldin CH, Herlyn M, Westermark B. 1993. Platelet-derived growth factor (PDGF) in oncogenesis: Development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci 90: 393-397.
12. Fujita Y, Maruyama S, Kogo H, Matsuo S, Fujimoto T. 2004. Caveolin-1 in mesangial cells suppresses MAP kinase activation and cell proliferation induced by bFGF and PDGF. Kidney Int 66: 1794-1804.
13. Grunwald IC, Korte M, Adelmann G, Plueck A, Kullander K, Adams RH, Frotscher M, Bonhoeffer T, Klein R. 2004. Hippocampal plasticity requires postsynaptic ephrinBs. Nat Neurosci 7: 33-40.
14. Hansen CG, Nichols BJ. 2009. Molecular mechanisms of clathrinindependent endocytosis. J Cell Sci 122: 1713-1721.
15. Hayashi K, Takahashi M, Kimura K, NishidaW, Saga H, Sobue K. 1999. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol 145: 727-740.
16. Keramati AR, Singh R, Lin A, Faramarzi S, Ye ZJ, Mane S, Tellides G, Lifton RP, Mani A. 2011. Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGFdependent vascular smooth muscle cell proliferation. Proc Natl Acad Sci 108: 1914-1918.
17. Kumari S, Mg S, Mayor S. 2010. Endocytosis unplugged: Multiple ways to enter the cell. Cell Res 20: 256-275.
18. Lanahan AA, Hermans K, Claes F, Kerley-Hamilton JS, Zhuang ZW, Giordano FJ, Carmeliet P, Simons M. 2010. VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis. Dev Cell 18: 713-724.
19. Lehti K, Rose NF, Valavaara S, Weiss SJ, Keski-Oja J. 2009. MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing. J Cell Sci 122: 126-135.
20. Lepore JJ, Cheng L, Min Lu M, Mericko PA, Morrisey EE, Parmacek MS. 2005. High-efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22α-Cre transgenic mice. Genesis 41: 179-184.
21. Lindahl P, Johansson BR, Leveen P, Betsholtz C. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277: 242-245.
22. Liu P, Ying Y, Ko YG, Anderson RG. 1996. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem 271: 10299-10303.
23. Mertens AE, Pegtel DM, Collard JG. 2006. Tiam1 takes PARt in cell polarity. Trends Cell Biol 16: 308-316.
24. Moes JJA, Zhou Y, Boonstra J. 2012. Co-localization of the PDGF β-receptor and actin during PDGF stimulation in mouse fibroblasts. ISRN Cell Biology 2012: doi: 10.5402/2012/568104.
25. Morcavallo A, Genua M, Palummo A, Kletvikova E, Jiracek J, Brzozowski AM, Iozzo RV, Belfiore A, Morrione A. 2012. Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A. J Biol Chem287: 11422-11436.
26. Muratoglu SC, Mikhailenko I, Newton C, Migliorini M, Strickland DK. 2010. Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with plateletderived growth factor receptor-β in endosomes and regulates activation of the MAPK pathway. J Biol Chem 285: 14308-14317.
27. Nakayama M, Nakayama A, van Lessen M, Yamamoto H, Hoffmann S, Drexler HC, Itoh N, Hirose T, Breier G, Vestweber D, et al. 2013. Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat Cell Biol 15: 249-260.
28. Olson LE, Soriano P. 2011. PDGFRβ signaling regulates mural cell plasticity and inhibits fat development. Dev Cell 20: 815-826.
29. Ostman A, Heldin CH. 2007. PDGF receptors as targets in tumor treatment. Adv Cancer Res 97: 247-274.
30. Pellet-Many C, Frankel P, Evans IM, Herzog B, Junemann-Ramirez M, Zachary IC. 2011. Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas. Biochem J 435: 609-618.
31. Pitulescu ME, Adams RH. 2010. Eph/ephrin molecules-a hub for signaling and endocytosis. Genes Dev 24: 2480-2492.
32. Raines EW. 2004. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 15: 237-254.
33. Sadowski L, Jastrzebski K, Kalaidzidis Y, Heldin CH, Hellberg C, Miaczynska M. 2013. Dynamin inhibitors impair endocytosis and mitogenic signaling of PDGF. Traffic 14: 725-736.
34. Sakane H, Yamamoto H, Kikuchi A. 2010. LRP6 is internalized by Dkk1 to suppress its phosphorylation in the lipid raft and is recycled for reuse. J Cell Sci 123: 360-368.
35. Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu ME, Acker T, Acker-Palmer A. 2010. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 465: 487-491.
36. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, Costantini F. 2001. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1: 4.
37. Sundberg C, Friman T, Hecht LE, Kuhl C, Solomon KR. 2009. Two different PDGF β-receptor cohorts in human pericytes mediate distinct biological endpoints. Am J Pathol 175: 171-189.
38. Tallquist MD, French WJ, Soriano P. 2003. Additive effects of PDGF receptor β signaling pathways in vascular smooth muscle cell development. PLoS Biol 1: E52.
39. Thiel G, Ekici M, Rossler OG. 2009. Regulation of cellular proliferation, differentiation and cell death by activated Raf. Cell Commun Signal 7: 8.
40. Uhrbom L, Hesselager G, Nister M, Westermark B. 1998. Induction of brain tumors in mice using a recombinant plateletderived growth factor B-chain retrovirus. Cancer Res 58: 5275-5279.
41. Vieira AV, Lamaze C, Schmid SL. 1996. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274: 2086-2089.
42. Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Luthi U, et al. 2010. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465: 483-486.
43. Yamamoto H, Sakane H, Michiue T, Kikuchi A. 2008. Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of β-catenin signaling. Dev Cell 15: 37-48.
44. Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, Hoshii Y, Tanaka N, Ricci R, Ishihara T, et al. 2005. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 11: 1330-1338.
45. Yu A, Rual JF, Tamai K, Harada Y, Vidal M, He X, Kirchhausen T. 2007. Association of Dishevelled with the clathrin AP-2 adaptor is required for Frizzled endocytosis and planar cell polarity signaling. Dev Cell 12: 129-141.
46. Zhou L, Takayama Y, Boucher P, Tallquist MD, Herz J. 2009. LRP1 regulates architecture of the vascular wall by controlling PDGFRβ-dependent phosphatidylinositol 3-kinase activation. PLoS ONE 4: e6922.
47. Zou Y, Hu Y, Metzler B, Xu Q. 1998. Signal transduction in arteriosclerosis: Mechanical stress-activated MAP kinases in vascular smooth muscle cells (review). Int J Mol Med 1: 827-834.